IRIS UniCatt

Bosello, Silvia Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.895
AS - Asia 4.677
EU - Europa 4.274
SA - Sud America 847
Continente sconosciuto - Info sul continente non disponibili 235
AF - Africa 122
OC - Oceania 21
Totale 17.071
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.664
SG - Singapore 2.153
CN - Cina 1.163
DE - Germania 1.145
IT - Italia 882
BR - Brasile 695
SE - Svezia 533
FR - Francia 484
VN - Vietnam 342
UA - Ucraina 243
IN - India 219
GB - Regno Unito 207
IE - Irlanda 182
FI - Finlandia 152
ID - Indonesia 148
PL - Polonia 115
CA - Canada 114
JP - Giappone 100
RU - Federazione Russa 95
HK - Hong Kong 86
BD - Bangladesh 80
TR - Turchia 80
KR - Corea 58
MX - Messico 55
AR - Argentina 53
IQ - Iraq 46
BE - Belgio 43
ZA - Sudafrica 35
NL - Olanda 34
PK - Pakistan 31
AT - Austria 30
ES - Italia 30
VE - Venezuela 28
IR - Iran 22
MA - Marocco 22
SA - Arabia Saudita 22
CO - Colombia 20
UZ - Uzbekistan 19
AU - Australia 18
EC - Ecuador 18
LT - Lituania 15
AE - Emirati Arabi Uniti 14
CI - Costa d'Avorio 13
JO - Giordania 13
KE - Kenya 13
CR - Costa Rica 11
MY - Malesia 11
TN - Tunisia 11
CZ - Repubblica Ceca 10
JM - Giamaica 10
PH - Filippine 10
PT - Portogallo 10
RO - Romania 10
CL - Cile 9
AZ - Azerbaigian 8
HN - Honduras 8
UY - Uruguay 8
TT - Trinidad e Tobago 7
CH - Svizzera 6
DK - Danimarca 6
EG - Egitto 6
EU - Europa 6
IL - Israele 6
NI - Nicaragua 6
PE - Perù 6
TW - Taiwan 6
BG - Bulgaria 5
HU - Ungheria 5
KG - Kirghizistan 5
AL - Albania 4
BO - Bolivia 4
ET - Etiopia 4
GR - Grecia 4
KW - Kuwait 4
LB - Libano 4
NG - Nigeria 4
NP - Nepal 4
PA - Panama 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CG - Congo 3
DZ - Algeria 3
MD - Moldavia 3
NO - Norvegia 3
PY - Paraguay 3
RS - Serbia 3
BB - Barbados 2
BY - Bielorussia 2
BZ - Belize 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
GT - Guatemala 2
KH - Cambogia 2
LV - Lettonia 2
MM - Myanmar 2
OM - Oman 2
PR - Porto Rico 2
QA - Qatar 2
SI - Slovenia 2
Totale 16.809
Salva come PNG Salva come JPEG
Città #
Singapore 1.245
Ashburn 709
San Jose 698
Chandler 592
Rome 210
Beijing 190
Dublin 181
New York 174
Ann Arbor 173
Hefei 169
Los Angeles 157
Jacksonville 138
Jakarta 129
Dearborn 121
Ho Chi Minh City 120
Lauterbourg 119
Milan 108
The Dalles 108
Munich 107
San Mateo 96
Tokyo 93
Houston 90
Wilmington 88
Woodbridge 85
Nanjing 84
Hanoi 82
Helsinki 80
Frankfurt am Main 79
Dallas 77
Seattle 77
Hong Kong 73
Boston 68
São Paulo 65
Kraków 64
Santa Clara 62
Fairfield 61
Moscow 59
Seoul 56
Chicago 54
Kent 53
Buffalo 48
Nürnberg 48
Atlanta 46
Marseille 43
Brussels 42
Lawrence 42
Paris 41
Boardman 40
Izmir 40
Nuremberg 40
Cattolica 37
Brooklyn 36
Bremen 34
Nanchang 34
Orem 34
Warsaw 33
Pune 32
Phoenix 31
Düsseldorf 29
Montreal 29
Redwood City 28
St Louis 27
Chennai 26
London 26
Shanghai 26
Guangzhou 25
Princeton 25
Toronto 25
San Francisco 24
Hebei 23
Johannesburg 23
Norwalk 23
Tianjin 23
Kunming 21
Rio de Janeiro 21
Stockholm 21
Hyderabad 20
Lancaster 20
Mexico City 20
Baghdad 19
Da Nang 19
Denver 19
Manchester 19
Philadelphia 18
Belo Horizonte 17
Tashkent 17
Augusta 16
Leawood 16
North Bergen 16
Trieste 16
Turku 16
Cambridge 15
Falls Church 15
Florence 15
Fremont 15
Detroit 14
Hangzhou 14
Abidjan 13
Amman 13
Andover 13
Totale 8.535
Salva come PNG Salva come JPEG
Nome #
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 363
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 348
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 324
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 293
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 271
Troponin in Stable Ischemic Heart Disease and Diabetes 271
Troponin in Stable Ischemic Heart Disease and Diabetes 262
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 253
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 240
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 240
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 236
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 227
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 213
Assessment of neurological manifestations in hospitalized patients with COVID-19 206
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 203
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 202
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 202
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 199
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 192
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 187
Adult-onset Still's disease following COVID-19 vaccination 187
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 184
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 180
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 175
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 173
Sarilumab use in severe SARS-CoV-2 pneumonia 173
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 171
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 171
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 171
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 169
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 169
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 169
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 165
(AS) TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. 161
A Comprehensive Natural Language Processing Pipeline for the Chronic Lupus Disease 159
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 159
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 153
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 152
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 151
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 150
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 146
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 145
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 143
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 143
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 143
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 140
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 140
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 139
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study 139
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 137
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 133
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study 132
Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease 126
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 126
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 126
An unusual lung involvement in scleroderma: lipoid pneumonia 125
Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression 122
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 120
Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice 119
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 118
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 118
null 118
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 117
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life 116
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 116
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 114
The human salivary proteome: a critical overview of the results obtained by different proteomic platforms 113
Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic 111
Computer-aided quantification of interstitial lung disease from high resolution computed tomography images in systemic sclerosis: correlation with visual reader-based score and physiologic tests 111
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 110
Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases 110
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 109
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 108
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement 108
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 107
Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients 106
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 105
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 103
Subclinical atherosclerosis and endothelial dysfunction in patients with polymyalgia rheumatica: a pilot study 100
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 98
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 98
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry 97
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 97
Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica 97
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 96
FUNZIONE CARDIORESPIRATORIA, ARTERIAL STIFFNESS E LIVELLI DI NT-PRO BNP IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE ALL’ESORDIO 93
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus 92
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 87
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 86
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19 85
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 84
Understanding Attitudes Toward Zoster Vaccination in the Hospital Setting: A Multidisciplinary Model to Contrast Vaccine Hesitancy in Fragile Patients—A Prospective Longitudinal Observational Study 84
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 83
Residual minimal disease activity in rheumatoid arthritis: a simple definition through an in-depth statistical analysis of the major outcome 80
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 80
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 79
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 79
What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? 79
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 78
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 76
Totale 14.864
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022708 0 0 23 56 61 44 36 102 39 86 106 155
2022/20231.685 214 235 127 271 83 191 83 138 152 14 56 121
2023/20241.067 36 278 53 57 38 146 73 76 21 31 149 109
2024/20252.587 49 51 218 85 255 114 111 108 355 271 550 420
2025/20266.451 898 211 390 725 1.248 372 1.112 330 366 397 211 191
2026/20271.493 310 968 215 0 0 0 0 0 0 0 0 0
Totale 17.071